NCT04102072

Brief Summary

Objective:

  1. 1.To evaluate the consistency of cardiac output measured by different hemodynamic monitoring methods in patients with VA-ECMO
  2. 2.To evaluate whether different hemodynamic monitoring methods can accurately detect the trend of cardiac output changes

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 23, 2019

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

September 10, 2019

Completed
15 days until next milestone

First Posted

Study publicly available on registry

September 25, 2019

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2024

Completed
Last Updated

September 26, 2019

Status Verified

September 1, 2019

Enrollment Period

4.9 years

First QC Date

September 10, 2019

Last Update Submit

September 24, 2019

Conditions

Keywords

pulmonary artery catheterechocardiographyfluid responsivenessextracorporeal membrane oxygenation

Outcome Measures

Primary Outcomes (3)

  • Baseline Cardiac Output measurement

    Cardiac Output measured at baseline position( in a supine position with the head elevated to 15° for baseline measurements )

    within1 minute at baseline position

  • Cardiac Output measurement afterTrendelenburg Maneuver

    Cardiac Output measured after Trendelenburg Maneuver

    1 minute after starting Trendelenburg Maneuver

  • Cardiac Output measurement after Dobutamine stress test

    Cardiac Output measured after dobutamine stress test

    5 minutes after dobutamine stress test

Study Arms (2)

Trendelenburg Maneuver

EXPERIMENTAL

The Trendelenburg position is a common treatment in medicine.It is used either as a diagnostic tool to assess fluid loading response or as a therapeutic maneuver pending fluid resuscitation.With the advantage of autotransfusion readily available,the Trendelenburg position is used for expected instantaneous effect on cardiovascular performance.

Diagnostic Test: Trendelenburg Maneuver

dobutamine stress test

EXPERIMENTAL

Dobutamine is a selective beta 1 receptor agonist. It \[\<10 ug/(kg.min)\] can effectively increase myocardial contractility.

Diagnostic Test: dobutamine stress test

Interventions

Trendelenburg ManeuverDIAGNOSTIC_TEST

In the Trendelenburg position, the body is laid supine with the feet higher than the head by 15-30 degrees. The venous return increases in the trendelenburg position which in turn increases the stroke volume.

Trendelenburg Maneuver
dobutamine stress testDIAGNOSTIC_TEST

Dobutamine was infused intravenously at the initial dose of 2.5 ug/kg/min. Echocardiography was performed after 5-10 minutes of continuous infusion, and hemodynamic data were recorded.

dobutamine stress test

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • cardiac surgery
  • treatment with VA-ECMO
  • mechanical ventilation
  • hemodynamic monitoring according to patient's condition (PAC, Flotrac, echocardiography)

You may not qualify if:

  • age \< 18
  • cardiac arrhythmia
  • moderate to severe aortic, mitral and tricuspid regurgitation
  • active hemorrhage
  • IABP
  • spontaneous triggering of the ventilator

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zhongshan hospital, Fudan university

Shanghai, 200032, China

RECRUITING

Study Officials

  • Zhe Luo, Doctor

    Fudan University

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 10, 2019

First Posted

September 25, 2019

Study Start

August 23, 2019

Primary Completion

August 1, 2024

Study Completion

August 1, 2024

Last Updated

September 26, 2019

Record last verified: 2019-09

Locations